{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:53:29Z","timestamp":1777870409376,"version":"3.51.4"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T00:00:00Z","timestamp":1404259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s40620-014-0117-5","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T03:41:20Z","timestamp":1404272480000},"page":"187-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pemetrexed induced acute kidney injury in patients with non-small cell lung cancer: reversible and chronic renal damage"],"prefix":"10.1093","volume":"28","author":[{"given":"Giuseppe","family":"Rombol\u00e0","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Vaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Trezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Chiappini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Falqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Londrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,7,2]]},"reference":[{"issue":"14","key":"117_CR1","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21(14):2636\u20132644","journal-title":"J Clin Oncol"},{"issue":"7","key":"117_CR2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/JTO.0b013e31817c73d6","volume":"3","author":"A Santoro","year":"2008","unstructured":"Santoro A, O\u2019Brien ME, Stahe RA, Nackaerts K, Baas P, Karthaus M, Eberhardt W, Paz-Ares L, Sundstrom L, Liu Y, Ripoche V, Blatter J, Visseren-Gru CM, Manegold C (2008) Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemona\u0131ve patients with malignant pleural mesothelioma: results of the international expanded access program. J Thorac Oncol 3(7):756\u2013763","journal-title":"J Thorac Oncol"},{"issue":"3","key":"117_CR3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cllc.2012.10.001","volume":"14","author":"WH Schuette","year":"2013","unstructured":"Schuette WH, Gr\u00f6schel A, Sebastian M, Andreas S, M\u00fcller T, Schneller T, Guetz S, Eschbach C, Bohnet S, Leschinger MI, Reck M (2013) A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or metastatic non-small-cell lung cancer. Clin Lung Cancer 14(3):215\u2013223","journal-title":"Clin Lung Cancer"},{"issue":"2 Suppl 2","key":"117_CR4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.seminoncol.2005.02.008","volume":"32","author":"MA Socinski","year":"2005","unstructured":"Socinski MA, Stinchcombe TE, Hayes DN (2005) The evolving role of pemetrexed (Alimta) in lung cancer. Semin Oncol 32(2 Suppl 2):16\u201322 (Review)","journal-title":"Semin Oncol"},{"issue":"9699","key":"117_CR5","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(09)61497-5","volume":"374","author":"T Ciuleanu","year":"2009","unstructured":"Ciuleanu T, Brodowicz T, Zielinski C et al (2009) Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study. Lancet 374(9699):1432\u20131440","journal-title":"Lancet"},{"issue":"19","key":"117_CR6","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1200\/JCO.2008.20.9114","volume":"27","author":"BH Gr\u00f8nberg","year":"2009","unstructured":"Gr\u00f8nberg BH, Bremnes RM, Fl\u00f8tten O et al (2009) Phase III study by the Norwegian Lung Cancer Study Group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol 27(19):3217\u20133224","journal-title":"J Clin Oncol"},{"issue":"9","key":"117_CR7","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","volume":"22","author":"N Hanna","year":"2004","unstructured":"Hanna N, Shepherd FA, Fossella FV et al (2004) Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 22(9):1589\u20131597","journal-title":"J Clin Oncol"},{"key":"117_CR8","unstructured":"http:\/\/www.drugs.com\/pro\/alimta.html . Accessed 26 Dec 2012"},{"key":"117_CR9","unstructured":"http:\/\/www.uptodate.com . Accessed 27 Feb 2014"},{"key":"117_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.ajkd.2007.05.008","volume":"50","author":"A Levin","year":"2007","unstructured":"Levin A, Warnock DG, Mehta RL et al (2007) Improving outcomes from acute kidney injury: report of an initiative. Am J Kidney Dis 50:1\u20134","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"117_CR11","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1200\/JCO.2006.09.9887","volume":"26","author":"J Jassem","year":"2008","unstructured":"Jassem J, Ramlau R, Santoro A et al (2008) Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma. J Clin Oncol 26(10):1698\u20131704","journal-title":"J Clin Oncol"},{"key":"117_CR12","unstructured":"http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm . Accessed 27 Feb 2014"},{"key":"117_CR13","unstructured":"http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2004\/021462lbl.pdf . Accessed 27 Feb 2014"},{"key":"117_CR14","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1200\/JCO.2012.47.1102","volume":"31","author":"LG Paz-Ares","year":"2013","unstructured":"Paz-Ares LG, De Marinis F, Dediu M et al (2013) PARAMOUNT: final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. J Clin Oncol 31:2895\u20132902","journal-title":"J Clin Oncol"},{"issue":"5","key":"117_CR15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1053\/j.ajkd.2011.04.030","volume":"58","author":"IG Glezerman","year":"2011","unstructured":"Glezerman IG, Pietanza MC, Miller V, Seshan SV (2011) Kidney tubular toxicity of maintenance pemetrexed therapy. Am J Kidney Dis 58(5):817\u2013820","journal-title":"Am J Kidney Dis"},{"key":"117_CR16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1385\/MO:23:3:419","volume":"23","author":"V Vootukuru","year":"2006","unstructured":"Vootukuru V, Liew YP, Nally JV Jr (2006) Pemetrexed-induced acute renal failure, nephrogenic diabetes insipidus, and renal tubular acidosis in a patient with non-small cell lung cancer. Med Oncol 23:419\u2013422","journal-title":"Med Oncol"},{"key":"117_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000208377","volume":"2","author":"J Michels","year":"2009","unstructured":"Michels J, Spano JP, Brocheriou I, Deray G, Khayat D, Izzedine H (2009) Acute tubular necrosis and interstitial nephritis during pemetrexed therapy. Case Rep Oncol 2:53\u201356","journal-title":"Case Rep Oncol"},{"key":"117_CR18","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3109\/0886022X.2010.501930","volume":"32","author":"A Stavroulopoulos","year":"2010","unstructured":"Stavroulopoulos A, Nakopoulou L, Xydakis AM, Aresti V, Nikolakopoulou A, Klouvas G (2010) Interstitial nephritis and nephrogenic diabetes insipidus in a patient treated with pemetrexed. Ren Fail 32:1000\u20131004","journal-title":"Ren Fail"},{"key":"117_CR19","first-page":"610","volume":"29","author":"JM Porta","year":"2009","unstructured":"Porta JM, Vicente de Vera Florist\u00e1n C, Ingl\u00e1n PB, Jeric\u00f3 JF (2009) Acute renal failure associated with Pemetrexed (Alimta\u00ae). Nefrologia 29:610\u2013611","journal-title":"Nefrologia"},{"key":"117_CR20","doi-asserted-by":"crossref","unstructured":"Chauvet S, Courbebaisse M, Ronco P, Plaisier E. Pemetrexed-induced acute kidney injury leadind to chronic kidney disease. Clin Nephrol. 2014 (Epub ahead of print)","DOI":"10.5414\/CN107921"},{"key":"117_CR21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/ki.2008.356","volume":"74","author":"MA Perazella","year":"2008","unstructured":"Perazella MA, Markowitz GS (2008) Bisphosphonate nephrotoxicity. Kidney Int 74:1385\u20131393","journal-title":"Kidney Int"},{"key":"117_CR22","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1093\/ndt\/gfm209","volume":"22","author":"M Bodmer","year":"2007","unstructured":"Bodmer M, Amico P, Mihatsch MJ et al (2007) Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient. Nephrol Dial Transplant 22:2366\u20132370","journal-title":"Nephrol Dial Transplant"},{"key":"117_CR23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1523-1755.2004.00426.x","volume":"65","author":"YM Barri","year":"2004","unstructured":"Barri YM, Munshi NC, Sukumalchantra S et al (2004) Podocyte injury associated glomerulopathies induced by pamidronate. Kidney Int 65:634\u2013641","journal-title":"Kidney Int"},{"key":"117_CR24","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1681\/ASN.V1261164","volume":"12","author":"GS Markowitz","year":"2001","unstructured":"Markowitz GS, Appel GB, Fine PL et al (2001) Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 12:1164\u20131172","journal-title":"J Am Soc Nephrol"},{"key":"117_CR25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1365-2141.2002.03826.x","volume":"119","author":"R Desikan","year":"2002","unstructured":"Desikan R, Veksler Y, Raza S et al (2002) Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma. Br J Haematol 119:496\u2013499","journal-title":"Br J Haematol"},{"key":"117_CR26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00002018-199513040-00003","volume":"13","author":"MJ McKeage","year":"1995","unstructured":"McKeage MJ (1995) Comparative adverse effect profiles of platinum drugs. Drug Saf. 13:228\u2013244","journal-title":"Drug Saf."},{"key":"117_CR27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01973462","volume":"64","author":"J Hannemann","year":"1990","unstructured":"Hannemann J, Baumann K (1990) Nephrotoxicity of cisplatin, carboplatin and transplatin. Arch Toxicol 64:339\u2013400","journal-title":"Arch Toxicol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0117-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-014-0117-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0117-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:52Z","timestamp":1777564672000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/28\/2\/187\/8372207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["117"],"URL":"https:\/\/doi.org\/10.1007\/s40620-014-0117-5","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,2]]}}}